Quarterly report pursuant to Section 13 or 15(d)

DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Tables)

v3.10.0.1
DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Tables)
6 Months Ended
Jun. 30, 2018
Description Of Business And Basis Of Presentation  
Summary of non-controlling interest ownership percentage

As of June 30, 2018, the non-controlling interest ownership percentage for subsidiaries are as follows:

 

Subsidiary  

Percentage of

Non-controlling Interest

  Owner of Non-controlling Interest
Celtic Biotech Iowa, Inc.   5 %     Various
Caretta Therapeutics, LLC   35 %     K4 Enterprises
SMA Therapeutics, LLC   20 %     K4 Enterprises
Zika Therapeutics, LLC   20 %     K4 Enterprises